Dobrocky, Tomas; Piechowiak, Eike I.; Volbers, Bastian; Slavova, Nedelina; Kaesmacher, Johannes; Meinel, Thomas R.; Arnold, Marcel; Fischer, Urs; Jung, Simon; Gralla, Jan; Mordasini, Pasquale; Heldner, Mirjam R. (2021). Treatment and Outcome in Stroke Patients With Acute M2 Occlusion and Minor Neurological Deficits. Stroke, 52(3), pp. 802-810. American Heart Association 10.1161/STROKEAHA.120.031672
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Kaesmacher_Slavova_Treatment.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (276kB) |
BACKGROUND AND PURPOSE
Treatment in stroke patients with M2 segment occlusion of the middle cerebral artery presenting with mild neurological deficits is a matter of debate. The main purpose was to compare the outcome in patients with a minor stroke and a M2 occlusion.
METHODS
Consecutive intravenous thrombolysis (IVT) eligible patients admitted to the Bernese stroke center between January 2005 and January 2020 with acute occlusion of the M2 segment and National Institutes of Health Stroke Scale score ≤5 were included. Outcome was compared between IVT only versus endovascular therapy (EVT) including intra-arterial thrombolysis and mechanical thrombectomy (MT; ±IVT) and between IVT only versus MT only.
RESULTS
Among 169 patients (38.5% women, median age 70.2 years), 84 (49.7%) received IVT only and 85 (50.3%) EVT (±IVT), the latter including 39 (45.9%) treated with MT only. Groups were similar in sex, age, vascular risk factors, event cause, or preevent independency. Compared with IVT only, there was no difference in favorable outcome (modified Rankin Scale score, 0-2) for EVT (adjusted odds ratio, 0.96; adjusted P=0.935) or for MT only (adjusted odds ratio, 1.12; adjusted P=0.547) groups. Considering only patients treated after 2015, there was a significantly better 3-month modified Rankin Scale shift (adjusted P=0.032) in the EVT compared with the IVT only group.
CONCLUSIONS
Our study demonstrates similar effectiveness of IVT only versus EVT (±IVT), and of IVT only versus MT only in patients with peripheral middle cerebral artery occlusions and minor neurological deficits and indicates a possible benefit of EVT considering only patients treated after 2015. There is an unmet need for randomized controlled trials in this stroke field, including imaging parameters, and more sophisticated evaluation of National Institutes of Health Stroke Scale score subitems, neurocognition, and quality of life neglected by the standard outcome scales such as modified Rankin Scale and National Institutes of Health Stroke Scale score.
Actions (login required)
 |
Edit item |